{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:42Z","timestamp":1793896002110,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110084","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:26:22Z","timestamp":1781537182000},"page":"110084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3\/NF-\u03baB inhibitors for triple-negative breast Cancer therapy"],"prefix":"10.1016","volume":"180","author":[{"given":"Amira A.","family":"Abdellatef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Al-Kubeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa M.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris E.","family":"Georghiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Loksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botros Y.","family":"Beshay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan A.","family":"Bekhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110084_bb0005","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1039\/D5MD00053J","article-title":"Discovery of novel STAT3 inhibitors with anti-breast cancer activity: structure-based virtual screening, molecular dynamics and biological evaluation","volume":"16","author":"Wang","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110084_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13578-025-01359-0","article-title":"Classifications of triple-negative breast cancer: insights and current therapeutic approaches","volume":"15","author":"Chen","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bioorg.2026.110084_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clinimag.2021.08.013","article-title":"Screening mammography mitigates breast cancer disparities through early detection of triple negative breast cancer","volume":"80","author":"Bayard","year":"2021","journal-title":"Clin. Imaging"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110084_bb0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1245\/s10434-016-5631-3","article-title":"Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age","volume":"24","author":"Radosa","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bioorg.2026.110084_bb0025","doi-asserted-by":"crossref","first-page":"1645438","DOI":"10.3389\/fonc.2025.1645438","article-title":"Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies","volume":"15","author":"Mir","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110084_bb0030","doi-asserted-by":"crossref","first-page":"20474","DOI":"10.1038\/s41598-021-00018-x","article-title":"Automatic identification of triple negative breast cancer in ultrasonography using a deep convolutional neural network","volume":"11","author":"Ye","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110084_bb0035","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110084_bb0040","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110084_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102672","article-title":"Breaking barriers in triple negative breast cancer (TNBC)\u2013unleashing the power of antibody-drug conjugates (ADCs)","volume":"123","author":"Dri","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110084_bb0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.drudis.2021.09.020","article-title":"Advances in understanding the role of P-gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects","volume":"27","author":"Mirzaei","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110084_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110447","article-title":"Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: an updated review (from 2022 to 2024)","volume":"36","author":"Kang","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110084_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110084_bb0070","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1038\/s41598-024-53549-4","article-title":"Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers","volume":"14","author":"Bose","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110084_bb0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cas.12683","article-title":"Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed\/refractory hematological malignancies","volume":"106","author":"Ogura","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2026.110084_bb0080","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016645","article-title":"The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression","volume":"296","author":"Poria","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110084_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050755","article-title":"Targeting STAT3 for Cancer therapy: focusing on Y705, S727, or dual inhibition?","volume":"17","author":"Berkley","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110084_bb0090","article-title":"Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo","author":"Huang","year":"2015","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bioorg.2026.110084_bb0095","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/jm300207s","article-title":"Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein","volume":"55","author":"Debnath","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110084_bb0100","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","article-title":"Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells","volume":"69","author":"Xin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110084_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126084","article-title":"In-vitro anticancer evaluation of newly designed and characterized tri\/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: molecular docking and MD simulation approaches","volume":"249","author":"Mahapatra","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110084_bb0110","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4155\/fmc-2023-0020","article-title":"An overview of imidazole and its analogues as potent anticancer agents","volume":"15","author":"Abdullah","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105033","article-title":"Design and synthesis of 2-Substituted-4-benzyl-5-methylimidazoles as new potential anti-breast cancer agents to inhibit oncogenic STAT3 functions","volume":"113","author":"Beshay","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3109\/14756366.2015.1079184","article-title":"Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach","volume":"3","author":"Poli","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9258(18)84021-2","article-title":"A general reaction of amino acids","volume":"78","author":"Dakin","year":"1928","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jhet.5570390222","article-title":"Synthesis of imidazoles as novel emivirine and S-DABO analogues","volume":"39","author":"Loksha","year":"2002","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0135","first-page":"116","article-title":"Synthesis of 2-Hydroxymethyl-1H-imidazole from 1,3-Dihydroimidazole-2-thiones","volume":"1","author":"Loksha","year":"2004","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.110084_bb0140","doi-asserted-by":"crossref","first-page":"28065","DOI":"10.1038\/s41598-024-76533-4","article-title":"Synthesis and effect of 4-acetylphenylamine-based imidazole derivatives on migration and growth of 3D cultures of breast, prostate and brain cancer cells","volume":"14","author":"Golcien\u0117","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110084_bb0145","first-page":"365","article-title":"A facile amidation of chloroacetyl chloride using DBU","volume":"10","author":"Mishra","year":"2017","journal-title":"Int. J. Chem. Tech. Res."},{"key":"10.1016\/j.bioorg.2026.110084_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4236\/ijoc.2015.51003","article-title":"Synthesis, spectroscopic characterization and antimicrobial activity of some new 2-substituted imidazole derivatives","volume":"5","author":"Salman","year":"2015","journal-title":"Int. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0155","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1246\/bcsj.53.1385","article-title":"The palladium catalyzed nucleophilic substitution of aryl halides by thiolate anions","volume":"53","author":"Migita","year":"1980","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.bioorg.2026.110084_bb0160","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1246\/bcsj.58.3657","article-title":"Palladium-catalyzed reaction of stannyl sulfide with aryl bromide. Preparation of aryl sulfide","volume":"58","author":"Ko-sugi","year":"1985","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.bioorg.2026.110084_bb0165","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ejoc.200700978","article-title":"Efficient copper (I)-catalyzed C\u2013S cross coupling of thiols with aryl halides in water","volume":"2008","author":"Rout","year":"2008","journal-title":"Eur. J. Org. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110084_bb0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cclet.2019.07.012","article-title":"C-S coupling with nitro group as leaving group via simple inorganic salt catalysis","volume":"31","author":"Xuan","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110084_bb0175","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1021\/acsomega.3c09411","article-title":"Synthesis, anticancer activity, and in silico modeling of Alkylsulfonyl Benzimidazole derivatives: unveiling potent Bcl-2 inhibitors for breast Cancer","volume":"9","author":"Abbade","year":"2024","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110084_bb0180","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1021\/acsomega.1c06836","article-title":"New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-based derivatives as potential EGFRWT and EGFRT790M inhibitors: microwave-assisted synthesis, anticancer evaluation, and molecular docking study","volume":"7","author":"Hashem","year":"2022","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110084_bb0185","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ultsonch.2010.03.002","article-title":"An easy and fast ultrasonic selective S-alkylation of hetaryl thiols at room temperature","volume":"17","author":"Deligeorgiev","year":"2010","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bioorg.2026.110084_bb0190","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1039\/D4QO00260A","article-title":"Nickel catalyzed C\u2013S cross coupling of sterically hindered substrates enabled by flexible bidentate phosphines","volume":"11","author":"Lindenmaier","year":"2024","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.bioorg.2026.110084_bb0195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3892\/mco.2016.750","article-title":"Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis (review)","volume":"4","author":"Yan","year":"2016","journal-title":"Mol. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110084_bb0200","article-title":"The morphological effect of cisplatin drug on Cancer cells. Implications for breast Cancer treatment","volume":"9","author":"Mohamed","year":"2024","journal-title":"Adv. Clin. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110084_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: a review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110084_bb0210","article-title":"Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110084_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00280-025-04770-z","article-title":"Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function","volume":"95","author":"Yuan","year":"2025","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110084_bb0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3\u03b2 homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110084_bb0225","series-title":"BIOVIA Discovery Studio, Version 4.5; Dassault Syst\u00e8mes: San Diego, CA","year":"2024"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110084_bb0230","doi-asserted-by":"crossref","first-page":"18967","DOI":"10.1074\/jbc.M314037200","article-title":"Structural requirements for STAT3 SH2 domain recognition","volume":"279","author":"Shao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110084_bb0235","first-page":"2019","article-title":"Discovery of small-molecule STAT3 inhibitors: targeting the SH2 domain","volume":"25","author":"Ren","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110084_bb0240","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3892\/ijo.2014.2624","article-title":"Identification of hirsutine as an anti-metastatic phytochemical by targeting NF-\u03baB activation","volume":"45","author":"Lou","year":"2014","journal-title":"Int. J. Oncology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:53:48Z","timestamp":1793894028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0045206826006206"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110084","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3\/NF-\u03baB inhibitors for triple-negative breast Cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110084"}}